Detalhe da pesquisa
1.
A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancer.
Proc Natl Acad Sci U S A
; 121(4): e2318093121, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38232291
2.
POGZ promotes homology-directed DNA repair in an HP1-dependent manner.
EMBO Rep
; 23(1): e51041, 2022 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758190
3.
The SHCA adapter protein cooperates with lipoma-preferred partner in the regulation of adhesion dynamics and invadopodia formation.
J Biol Chem
; 295(31): 10535-10559, 2020 07 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32299913
4.
Clinical Potential of Kinase Inhibitors in Combination with Immune Checkpoint Inhibitors for the Treatment of Solid Tumors.
Int J Mol Sci
; 22(5)2021 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33807608
5.
p66ShcA functions as a contextual promoter of breast cancer metastasis.
Breast Cancer Res
; 22(1): 7, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31941526
6.
The Tyrosine Kinome Dictates Breast Cancer Heterogeneity and Therapeutic Responsiveness.
J Cell Biochem
; 117(9): 1971-90, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27392311
7.
Insights from transgenic mouse models of ERBB2-induced breast cancer.
Nat Rev Cancer
; 7(5): 389-97, 2007 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-17446858
8.
Peripheral blood cells inform on the presence of breast cancer: a population-based case-control study.
Int J Cancer
; 136(3): 656-67, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24931809
9.
A complex containing LPP and α-actinin mediates TGFß-induced migration and invasion of ErbB2-expressing breast cancer cells.
J Cell Sci
; 126(Pt 9): 1981-91, 2013 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23447672
10.
Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling.
Proc Natl Acad Sci U S A
; 109(8): 2802-7, 2012 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-21908711
11.
MTOR modulation induces selective perturbations in histone methylation which influence the anti-proliferative effects of mTOR inhibitors.
iScience
; 27(3): 109188, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38433910
12.
p66ShcA promotes malignant breast cancer phenotypes by alleviating energetic and oxidative stress.
Redox Biol
; 70: 103028, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38211442
13.
It takes two to tango in the microenvironment!
Breast Cancer Res
; 15(2): 102, 2013 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23510134
14.
Endoplasmic reticulum stress induces PRNP prion protein gene expression in breast cancer.
Breast Cancer Res
; 15(2): R22, 2013 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23497519
15.
ShcA signalling is essential for tumour progression in mouse models of human breast cancer.
EMBO J
; 27(6): 910-20, 2008 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-18273058
16.
p66ShcA potentiates the cytotoxic response of triple-negative breast cancers to PARP inhibitors.
JCI Insight
; 6(4)2021 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33470989
17.
STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer.
Nat Commun
; 12(1): 3299, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083537
18.
Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
Mol Cell Biol
; 27(18): 6361-71, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17636013
19.
CD44 Promotes PD-L1 Expression and Its Tumor-Intrinsic Function in Breast and Lung Cancers.
Cancer Res
; 80(3): 444-457, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31722999
20.
An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy.
Nat Commun
; 10(1): 2139, 2019 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31086176